GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » EBITDA Margin %

Oxford BioDynamics (Oxford BioDynamics) EBITDA Margin % : -1,995.82% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Oxford BioDynamics's EBITDA for the six months ended in Sep. 2023 was $-7.17 Mil. Oxford BioDynamics's Revenue for the six months ended in Sep. 2023 was $0.36 Mil. Therefore, Oxford BioDynamics's EBITDA margin for the quarter that ended in Sep. 2023 was -1,995.82%.


Oxford BioDynamics EBITDA Margin % Historical Data

The historical data trend for Oxford BioDynamics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics EBITDA Margin % Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -330.54 -977.50 -1,886.32 -4,008.62 -1,930.11

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,526.40 -2,974.11 -5,270.51 -1,841.57 -1,995.82

Competitive Comparison of Oxford BioDynamics's EBITDA Margin %

For the Biotechnology subindustry, Oxford BioDynamics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's EBITDA Margin % falls into.



Oxford BioDynamics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Oxford BioDynamics's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-12.179/0.631
=-1,930.11 %

Oxford BioDynamics's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-7.165/0.359
=-1,995.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics  (OTCPK:OXBOF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Oxford BioDynamics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (Oxford BioDynamics) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (Oxford BioDynamics) Headlines

From GuruFocus